$2.00
-0.29-12.66%
At close: -
$2.10
0.105.00%
After Hours: 7:56 PM EDT
Comments
Loading...
Relay Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RLAY | Benzinga
Relay Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.510
Quarterly Revenue Estimate
$11.11K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$10.01M
Analyze the earnings history of Relay Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RLAY | Relay Therapeutics | -$0.62 | -$0.51 | — | — | $10.01M | $11.11K | — | — | 05/01/2025 | Get Alert |
| RLAY | Relay Therapeutics | -$0.67 | -$0.55 | -$0.45 | 18.18% | $0.00 | $5.53M | $0.00 | -100.00% | 02/26/2025 | Get Alert |
| RLAY | Relay Therapeutics | -$0.54 | -$0.77 | -$0.63 | 18.18% | $25.20M | — | $0.00 | — | 11/06/2024 | Get Alert |
| RLAY | Relay Therapeutics | -$0.81 | -$0.73 | -$0.69 | 5.48% | $119.00K | $80.00K | $0.00 | -100.00% | 08/06/2024 | Get Alert |
| RLAY | Relay Therapeutics | -$0.78 | -$0.71 | -$0.62 | 12.68% | $226.00K | $90.00K | $10.01M | 11018.89% | 05/02/2024 | Get Alert |
| RLAY | Relay Therapeutics | -$0.56 | -$0.73 | -$0.67 | 8.22% | $253.00K | $130.00K | $0.00 | -100.00% | 02/22/2024 | Get Alert |
| RLAY | Relay Therapeutics | -$0.76 | -$0.83 | -$0.54 | 34.94% | $344.00K | — | $25.20M | — | 11/02/2023 | Get Alert |
| RLAY | Relay Therapeutics | -$0.71 | -$0.81 | -$0.81 | 0.00% | $365.00K | $750.00K | $119.00K | -84.13% | 08/08/2023 | Get Alert |
| RLAY | Relay Therapeutics | -$0.57 | -$0.69 | -$0.78 | -13.04% | $419.00K | $210.00K | $226.00K | 7.62% | 05/04/2023 | Get Alert |
| RLAY | Relay Therapeutics | -$0.62 | -$0.70 | -$0.56 | 20.00% | $567.00K | $3.30M | $253.00K | -92.33% | 02/23/2023 | Get Alert |
| RLAY | Relay Therapeutics | -$0.66 | -$0.71 | -$0.76 | -7.04% | $666.00K | $1.66M | $344.00K | -79.28% | 11/03/2022 | Get Alert |
| RLAY | Relay Therapeutics | -$0.64 | -$0.63 | -$0.71 | -12.70% | $844.00K | $1.93M | $365.00K | -81.09% | 08/04/2022 | Get Alert |
| RLAY | Relay Therapeutics | -$0.47 | -$0.62 | -$0.57 | 8.06% | $952.00K | $170.00K | $419.00K | 146.47% | 05/05/2022 | Get Alert |
| RLAY | Relay Therapeutics | $4.52 | — | -$0.62 | — | $82.65M | — | $567.00K | — | 02/24/2022 | Get Alert |
| RLAY | Relay Therapeutics | -$3.00 | -$0.64 | -$0.66 | -3.12% | $0.00 | $110.00K | $666.00K | 505.45% | 11/10/2021 | Get Alert |
| RLAY | Relay Therapeutics | — | -$0.45 | -$0.64 | -42.22% | — | $8.00M | $844.00K | -89.45% | 08/12/2021 | Get Alert |
| RLAY | Relay Therapeutics | -$5.99 | -$0.48 | -$0.47 | 2.08% | — | $952.00K | $952.00K | 0.00% | 05/13/2021 | Get Alert |
| RLAY | Relay Therapeutics | — | — | $4.52 | — | — | — | $82.65M | — | 03/25/2021 | Get Alert |
| RLAY | Relay Therapeutics | -$5.53 | -$0.35 | -$3.00 | -757.14% | — | — | $0.00 | — | 11/12/2020 | Get Alert |
Relay Therapeutics (RLAY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-0.45 | $-0.55 | 18.2 % |
| Q3 | 2024-11-06 | $-0.63 | $-0.77 | 18.2 % |
| Q2 | 2024-08-06 | $-0.69 | $-0.73 | 5.48 % |
| Q1 | 2024-05-02 | $-0.62 | $-0.71 | 12.7 % |
Relay Therapeutics (RLAY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $0 | $5.53M | -100.0 % |
| Q2 | 2024-08-06 | $0 | $80.00K | -100.0 % |
| Q1 | 2024-05-02 | $10.01M | $90.00K | 11018.9 % |
| Q4 | 2024-02-22 | $0 | $130.00K | -100.0 % |
FAQ
When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?
Relay Therapeutics (RLAY) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Relay Therapeutics (NASDAQ:RLAY)?
The Actual EPS was $-0.45, which beat the estimate of $-0.55.
What were Relay Therapeutics’s (NASDAQ:RLAY) revenues?
The Actual Revenue was $0K, which missed the estimate of $5.5M.
Browse earnings estimates, EPS, and revenue on all stocks.